Efficacy and safety of adeno‐associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy
Open Access
- 26 September 2006
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (1) , 16-24
- https://doi.org/10.1111/j.1538-7836.2006.02220.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Long-Term Efficacy of Adeno-Associated Virus Serotypes 8 and 9 in Hemophilia A Dogs and MiceHuman Gene Therapy, 2006
- Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID miceBlood, 2006
- Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman PrimatesMolecular Therapy, 2006
- Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in MiceJournal of Virology, 2005
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Blood, 2004
- Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivoBlood, 2002
- Lack of Germline Transmission of Vector Sequences Following Systemic Administration of Recombinant AAV-2 Vector in MalesMolecular Therapy, 2001
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991